Patient-Friendly Explanation
Tamoxifen is a hormone treatment given for several years after some breast cancers. It can cause gradual weight gain, especially around the waist, and this is a common effect rather than a sign the treatment is failing.
Clinical Definition
Tamoxifen acts as a partial oestrogen-receptor agonist with tissue-specific effects. Adjuvant therapy is associated with reduced resting energy expenditure, a shift toward central fat distribution and, in observational series, mean gains of two to four kilograms over two to three years, compounded by treatment-related fatigue and reduced physical activity.
Why It Matters
Weight gain is never a reason to stop endocrine therapy. Structured nutrition and resistance exercise during treatment protect lean mass and support long-term outcomes, and NuLifeCare Singapore coordinates weight care with the treating oncologist.